Covered recipient · General Payments record
JESSICA EVANS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,085.17
- Reported across 50 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $493.13 | 19 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $315.15 | 11 |
| Neurocrine BioSciences, Inc. | $92.24 | 3 |
| CSL Behring | $31.79 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.65 | 1 |
| Acerta Pharma LLC | $13.79 | 1 |
| INSIGHTEC,INC | $11.51 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $21.81 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083180 | CMS |
| ABBVIE INC. | $23.13 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083182 | CMS |
| ABBVIE INC. | $18.85 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083184 | CMS |
| ABBVIE INC. | $25.54 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083186 | CMS |
| ABBVIE INC. | $24.01 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083188 | CMS |
| ABBVIE INC. | $23.75 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083190 | CMS |
| ABBVIE INC. | $21.94 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083192 | CMS |
| ABBVIE INC. | $8.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083194 | CMS |
| ABBVIE INC. | $31.22 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083196 | CMS |
| ABBVIE INC. | $98.75 | 09/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083198 | CMS |
| ABBVIE INC. | $17.73 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107083200 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.79 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104696388 | CMS |
| CSL Behring | $31.79 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134620785 | CMS |
| InSightec,Inc | $6.82 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110446503 | CMS |
| InSightec,Inc | $4.69 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110446505 | CMS |
| Neurocrine Biosciences, Inc. | $30.02 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150939443 | CMS |
| Neurocrine Biosciences, Inc. | $35.12 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150931963 | CMS |
| Neurocrine Biosciences, Inc. | $27.10 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150947580 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.65 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137740574 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.